Soquelitinib Shows Promise in Atopic Dermatitis Trial
Corvus Pharmaceuticals released interim Phase 1 data for soquelitinib, an oral ITK inhibitor, in patients with moderate to severe...
eClinical Tech News
UTRx Therapeutics Announces IND Submission for C-MYC mRNA Drug
UTRx Inc. submitted an Investigational New Drug (IND) application to the FDA for UTRxM1-18, a novel therapeutic targeting c-MYC...
Kriya at ARVO 2025: Vision Research
Kriya Therapeutics presented preclinical data at the ARVO Annual Meeting for KRIYA-825, a gene therapy candidate for Geographic Atrophy...
Yamo Pharma L1-79 Shows Strong Phase 2 Autism Results
Yamo Pharmaceuticals announced positive Phase 2 trial results for L1-79, a drug targeting core autism spectrum disorder (ASD) symptoms,...
Zervimesine Reduced Lesion Growth in Phase 2 Geographic Atrophy Study
Cognition Therapeutics announced topline results from its Phase 2 MAGNIFY trial of zervimesine, an oral drug for geographic atrophy...
Syndax Announces Pivotal Revumenib AML Data Publication in Blood
Syndax Pharmaceuticals announced positive Phase 2 trial results for revumenib, a menin inhibitor, in patients with relapsed or refractory...
Arcutis: Positive Zoryve Data in Psoriasis Trial
Arcutis Biotherapeutics announced positive Phase 3 trial results for ZORYVE foam 0.3% in treating scalp and body psoriasis. The...
Inspira Art100 System Approved for Organ Transplant Patients
Inspira Technologies’ INSPIRA™ ART100 system has been approved for clinical validation by Israel’s largest healthcare provider during organ transplant...
Preclinical Data on Assembly Biosciences’ HBV and HDV Inhibitors at EASL 2025
Assembly Biosciences presented preclinical and in vitro data for two hepatitis drug candidates, ABI-6250 and ABI-4334, at the European...
Alzamend Neuro and Qmenta in AI Imaging Trial
Alzamend Neuro is partnering with QMENTA to utilize their AI-driven imaging platform in five upcoming Phase II clinical trials...